Movement Alert|Marvell Technology Rises 3.08% in Pre-Market Trading, Morgan Stanley Raises Price Target to $268

Market Focus
Sep 21

On September 21, Marvell Technology rose 3.08% in pre-market trading, trading at $251.7 USD/share, with turnover of approximately $69.75 million. The move came after Morgan Stanley raised its price target on the stock from $246 to $268 while maintaining an Equalweight rating.

According to analyst consensus data, Marvell Technology currently carries an average rating of Buy with a mean price target of $294.52, suggesting further upside potential from current levels. The price target revision follows a string of positive developments for the company. Earlier in the week, Marvell and GlobalFoundries announced an expanded multiyear agreement to increase silicon germanium technology capacity at GlobalFoundries' Burlington, Vermont facility, targeting surging demand for next-generation high-speed optical connectivity in AI and cloud data centers. Additionally, Marvell partnered with Microsoft and Utimaco to launch Azure Payment HSM v2, a cloud-native payment security platform now in public preview across the Western US and Western Europe.

Within the Semiconductors sector, Intel rose 5.78%, Advanced Micro Devices gained 3.29%, Micron Technology added 2.09%, Broadcom climbed 1.72%, and NVIDIA edged up 0.91%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10